Cardica to Announce Fiscal 2016 Second Quarter Financial Results on Thursday, February 4, 2016
26 January 2016 - 8:05AM
Cardica, Inc. (Nasdaq:CRDC) today announced that it will release
financial results for its fiscal second quarter ended December 31,
2015, on Thursday, February 4, 2016, after the markets close.
Cardica’s management will host a conference call at 4:30 p.m.
Eastern Time to discuss the financial results and provide an update
on the company’s business.
Conference Call DetailsTo access the live
conference call on February 4, 2016, at 4:30 p.m. Eastern Time via
phone, please dial 800-901-5241 from the United States and Canada
or 617-786-2963 internationally. The conference ID is 61547195.
Please dial in approximately 10 minutes prior to the start of the
call. A telephone replay will be available beginning approximately
four hours after the call through February 11, 2016, and may be
accessed by dialing 888-286-8010 from the United States and Canada
or 617-801-6888 internationally. The replay passcode is
80216818.
To access the live and subsequently archived webcast of the
conference call, go to the Investor Relations section of the
company’s website at www.cardica.com. Please connect to the website
at least 15 minutes prior to the presentation to allow for any
necessary software downloads.
The webcast is also being distributed through the Thomson
StreetEvents Network. Institutional investors can access the call
via Thomson StreetEvents at www.streetevents.com, a
password-protected event management site.
About CardicaCardica designs and
manufactures proprietary stapling and anastomotic devices for
cardiac and minimally invasive surgical procedures. Cardica's
technology portfolio is intended to reduce operating time and
facilitate minimally invasive and robot-assisted surgeries.
Cardica’s MicroCutter XCHANGE® 30, that includes a cartridge-based
articulating surgical stapling device with a five-millimeter shaft
diameter and staples, is manufactured and cleared for use in the
United States for transection and resection in multiple open or
minimally invasive urologic, thoracic and pediatric surgical
procedures, as well as application for transection, resection
and/or creation of anastomoses in the small and large intestine and
the transection of the appendix. The MicroCutter XCHANGE 30 White
Cartridge staple has application in vascular tissue. In
addition, Cardica manufactures and markets its automated
anastomosis systems, the C-Port® Distal Anastomosis Systems and
PAS-Port® Proximal Anastomosis System for coronary artery bypass
graft (CABG) surgery, and has shipped over 56,500 units throughout
the world.
Contact:
Bob Newell
Vice President, Finance and Chief Financial Officer
(650) 331-7133
investors@cardica.com